Lemaitre Vascular Inc
LMATHealthcare·Medical Instruments & Supplies·USA·Small·NASD·Nov 11 • 3:59 PM ET
79.29+0.27 (0.34%)
2026-11-11 22:02 CET
Market cap
1,808.05 USD m
Revenue, TTM
269.36 USD m
Net income, TTM
63.34 USD m
Free cash flow, TTM
67.00 USD m
EPS diluted, TTM
2.71
P/E
29.31
Price
LMAT against its 20, 50 and 200-day averages2050200miss
32.8% under the 52-week high of 118.01 on 14 Apr 2026. 52-week low 78.22 on 21 Sep 2026. Last 15 sessions, 13.6% high to low
Volume 0.46× normal · the line is the 50-bar volume average
Profile
LMAT52-week range, 3% of the way up
78.22118.01
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
| Index | RUT |
|---|---|
| Employees | 655 |
| IPO | Oct 19, 2006 |
| Beta | 0.49 |
| ATR, 14d | 2.85 |
| Rel volume | 0.46 |
| Short float | 7.78% |
| Insider own | 6.91% |
| Inst own | 99.08% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | 1.81B |
| Enterprise Value | 1.61B |
| Income | 63.34M |
| Sales | 269.36M |
| Book/sh | 18.89 |
| Cash/sh | 17.03 |
| Dividend Est. | - |
| Dividend TTM | 0.95 (1.20%) |
| Dividend Ex-Date | Nov 19, 2026 |
| Dividend Gr. 3/5Y | 16.96% 16.05% |
| Payout | 31.77% |
| Employees | 655 |
| IPO | Oct 19, 2006 |
Ratios
| P/E | 29.31 |
|---|---|
| Forward P/E | 25.17 |
| PEG | 2.28 |
| P/S | 6.74 |
| P/B | 4.20 |
| P/C | 4.66 |
| P/FCF | 27.08 |
| EV/EBITDA | 18.88 |
| EV/Sales | 5.99 |
| Quick Ratio | 12.54 |
| Current Ratio | 14.19 |
| Debt/Eq | 0.44 |
| LT Debt/Eq | 0.43 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 2.71 |
|---|---|
| EPS next Y | 3.15 |
| EPS next Q | 0.73 |
| EPS this Y | 11.18% |
| EPS next Y | 12.43% |
| EPS next 5Y | 11.02% |
| EPS past 3/5Y | 39.34% 19.43% |
| Sales past 3/5Y | 15.58% 14.05% |
| EPS Y/Y TTM | 17.64% |
| Sales Y/Y TTM | 11.83% |
| EPS Q/Q | -13.50% |
| Sales Q/Q | 11.34% |
| Earnings | Nov 04 AMC |
| EPS/Sales Surpr. | -5.29% 0.86% |
Ownership
| Insider Own | 6.91% |
|---|---|
| Insider Trans | -3.56% |
| Inst Own | 99.08% |
| Inst Trans | 3.61% |
| ROA | 10.10% |
| ROE | 15.62% |
| ROIC | 10.25% |
| Gross Margin | 70.46% |
| Oper. Margin | 27.73% |
| Profit Margin | 23.51% |
| SMA20 | -4.12% |
| SMA50 | -2.64% |
| SMA200 | -15.91% |
| Trades | - |
Technical
| Shs Outstand | 22.88M |
|---|---|
| Shs Float | 21.30M |
| Short Float | 7.78% |
| Short Ratio | 5.62 |
| Short Interest | 1.66M |
| 52W High | 118.01 -32.81% |
| 52W Low | 78.22 1.37% |
| Volatility | 4.77% 3.19% |
| ATR (14) | 2.85 |
| RSI (14) | 43.73 |
| Beta | 0.49 |
| Rel Volume | 0.46 |
| Avg Volume | 294.88K |
| Volume | 136,968 |
Performance
| Perf Week | -9.82% |
|---|---|
| Perf Month | -2.77% |
| Perf Quarter | -3.22% |
| Perf Half Y | -19.23% |
| Perf YTD | -2.23% |
| Perf Year | -12.26% |
| Perf 3Y | 63.32% |
| Perf 5Y | 46.35% |
| Perf 10Y | 233.01% |
| Recom | 2.00 |
| Target Price | 99.29 |
| Prev Close | 79.02 |
| Price | 79.29 |
| Change % | 0.34% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Aug 05, 2026 | Downgrade | BBarrington Research | Outperform → Mkt Perform | ||
| Aug 06, 2025 | Upgrade | BBarrington Research | Mkt Perform → Outperform | $95 | +19.8% |
| Feb 28, 2025 | Downgrade | OOppenheimer | Outperform → Perform | ||
| Feb 28, 2025 | Downgrade | BBarrington Research | Outperform → Mkt Perform | ||
| Feb 13, 2025 | Initiated | WWells Fargo | Equal Weight | $95 | +19.8% |
| Oct 15, 2024 | Initiated | CCantor Fitzgerald | Neutral | $96 | +21.1% |
| Aug 02, 2024 | Resumed | LLake Street | Buy | $85 → $105 | +32.4% |
| May 31, 2024 | Resumed | RROTH MKM | Buy | $100 | +26.1% |
| Apr 26, 2024 | Upgrade | SStifel | Hold → Buy | $59 → $75 | -5.4% |
| Feb 06, 2024 | Resumed | KKeyBanc Capital Markets | Sector Weight |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ANGO | Angiodynamic Inc | 522.32M |
| MMSI | Merit Medical Systems Inc | 5.28B |
| TFX | Teleflex Incorporated | 6.20B |
| AORT | Artivion Inc | 980.19M |
| BDX | Becton Dickinson & Co | 58.44B |
| PEN | Penumbra Inc | 12.68B |
| IART | Integra Lifesciences Holdings Corp | 1.15B |
| BSX | Boston Scientific Corp | 65.44B |
| AXGN | Axogen Inc | 3.50B |
| MDT | Medtronic Plc | 130.01B |
Insider trading
latest 14 of 76| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Roush John A | Director | Sep 01 '26 | Option Exercise | 48.60 | 3,444 | 167,378 | 7,386 | Sep 03 04:37 PM |
| BRIDGET A ROSS | Director | Jul 29 '26 | Proposed Sale | 103.94 | 4,322 | 449,241 | Jul 29 04:08 PM | |
| LeMaitre George W | Chairman and CEO | May 08 '26 | Sale | 108.69 | 27,881 | 3,030,400 | 1,430,019 | May 11 06:22 PM |
| LeMaitre George W | Chairman and CEO | May 07 '26 | Sale | 107.64 | 18,600 | 2,002,013 | 1,457,900 | May 11 06:22 PM |
| Kamke Trent G | Senior V. P., Operations | May 08 '26 | Sale | 107.00 | 2,928 | 313,287 | 3,749 | May 11 05:13 PM |
| Ross Bridget A | Director | May 07 '26 | Option Exercise | 48.15 | 5,044 | 242,882 | 8,986 | May 11 05:10 PM |
| Ross Bridget A | Director | May 07 '26 | Sale | 111.10 | 5,044 | 560,366 | 3,942 | May 11 05:10 PM |
| Jasinski Lawrence J | Director | May 07 '26 | Option Exercise | 65.92 | 2,858 | 188,412 | 8,657 | May 11 05:08 PM |
| Jasinski Lawrence J | Director | May 07 '26 | Sale | 110.00 | 3,943 | 433,730 | 4,714 | May 11 05:08 PM |
| TRENT G KAMKE | Officer | May 08 '26 | Proposed Sale | 107.00 | 2,928 | 313,287 | May 08 04:21 PM | |
| BRIDGET A ROSS | Director | May 07 '26 | Proposed Sale | 111.10 | 5,044 | 560,366 | May 07 04:12 PM | |
| LAWRENCE J. JASINSKI | Director | May 07 '26 | Proposed Sale | 110.00 | 3,943 | 433,730 | May 07 04:04 PM | |
| Pellegrino Joseph P JR | Director | Apr 22 '26 | Option Exercise | 35.48 | 2,941 | 104,347 | 15,021 | Apr 23 07:53 PM |
| Kamke Trent G | Senior V. P., Operations | Mar 11 '26 | Option Exercise | 35.48 | 2,625 | 93,135 | 9,302 | Mar 13 04:42 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | AUM: 106.27B |
| SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | AUM: 11.33B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.38B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.06B |
| SPSM | State Street SPDR Portfolio S&P 600TM Small Cap ETF | AUM: 16.06B |
| IJT | iShares S&P Small-Cap 600 Growth ETF | AUM: 7.45B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.51B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.75B |
News
latest 14 of 200- LeMaitre to Participate in Upcoming Investor Conferences (GlobeNewswire)
- LeMaitre Vascular Misses On EPS And Cuts Profit Guidance Again, Even As Organic Growth Accelerates To 12% (Earnings Whispers) +9.08% -5.04%
- LeMaitre: Q3 Earnings Snapshot (Associated Press)
- LeMaitre Q3 2026 Financial Results (GlobeNewswire)
- LeMaitre Faces A Credibility Test After Its First Guidance Cut As Autograph Carries The Load (Earnings Whispers)
- LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 (GlobeNewswire)
- LeMaitre to Participate at Upcoming Investor Conferences in September (GlobeNewswire)
- LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (GlobeNewswire)
- LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ... (GuruFocus.com) -25.32%
- LeMaitre: Q2 Earnings Snapshot (Associated Press)
- LeMaitre Q2 2026 Financial Results (GlobeNewswire)
- LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026 (GlobeNewswire)
- LeMaitre to Participate at Upcoming Investor Conferences in June (GlobeNewswire)
- LeMaitre to Present at the Bank of America Healthcare Conference (GlobeNewswire)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-04 | 0.650 | 0.686 | 0.650 | 67.97 | 67.39 | 8 |
| 2026Q2 | 2026-08-04 | 0.740 | 0.807 | 0.695 | 70.38 | 71.47 | 9 |
| 2026Q1 | 2026-05-05 | 0.680 | 0.661 | 0.681 | 66.55 | 66.67 | 10 |
| 2025Q4 | 2026-02-25 | 0.680 | 0.664 | 0.678 | 64.45 | 62.82 | 11 |
| 2025Q3 | 2025-11-06 | 0.750 | 0.566 | 0.753 | 61.05 | 62.17 | 11 |
| 2025Q2 | 2025-08-05 | 0.600 | 0.567 | 0.602 | 63.15 | 62.48 | 11 |
| 2025Q1 | 2025-05-01 | 0.480 | 0.498 | 0.481 | 59.87 | 57.61 | 11 |
| 2024Q4 | 2025-02-27 | 0.490 | 0.493 | 0.488 | 55.81 | 55.98 | 11 |
| 2024Q3 | 2024-10-31 | 0.490 | 0.435 | 0.488 | 54.82 | 53.50 | 10 |
| 2024Q2 | 2024-08-01 | 0.520 | 0.472 | 0.520 | 55.85 | 54.98 | 9 |
| 2024Q1 | 2024-05-02 | 0.440 | 0.388 | 0.438 | 53.48 | 51.50 | 8 |
| 2023Q4 | 2024-02-27 | 0.380 | 0.356 | 0.377 | 46.85 | 49.01 | 8 |
| 2023Q3 | 2023-11-01 | 0.330 | 0.309 | 0.334 | 47.41 | 47.53 | 8 |
| 2023Q2 | 2023-08-01 | 0.360 | 0.317 | 0.361 | 48.89 | 48.08 | 7 |
| 2023Q1 | 2023-05-02 | 0.270 | 0.250 | 0.271 | 47.08 | 43.54 | 7 |
| 2022Q4 | 2023-02-23 | 0.250 | 0.256 | 0.253 | 40.95 | 41.00 | 7 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2017FY | 0.860 | 0.847 | 0.860 | 100.87 | 101.02 |
| 2018FY | 1.130 | 1.038 | 1.133 | 105.57 | 103.08 |
| 2019FY | 0.880 | 0.886 | 0.882 | 117.23 | 117.51 |
| 2020FY | 1.040 | 0.985 | 1.036 | 129.37 | 127.4 |
| 2021FY | 1.250 | 1.284 | 1.253 | 154.42 | 154.61 |
| 2022FY | 0.930 | 0.930 | 0.931 | 161.65 | 161.7 |
| 2023FY | 1.340 | 1.324 | 1.343 | 193.48 | 193.61 |
| 2024FY | 1.930 | 1.941 | 1.933 | 219.86 | 220.05 |
| 2025FY | 2.520 | 2.465 | 2.520 | 249.6 | 247.98 |
| 2026FY | - | 2.802 | - | - | 276.03 |
| 2027FY | - | 3.150 | - | - | 303.43 |
| 2028FY | - | 3.448 | - | - | 330.03 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-05 | 8 | 0 | 7 | 71.20 | 70.90 | 72.10 |
| 2026Q4 | S | 2026-11-04 | 8 | 0 | 0 | 72.24 | 72.00 | 72.55 |
| 2026Q4 | S | 2026-10-19 | 8 | 0 | 0 | 72.24 | 72.00 | 72.55 |
| 2026Q4 | S | 2026-08-13 | 8 | 0 | 3 | 72.24 | 72.00 | 72.55 |
| 2026Q4 | S | 2026-08-06 | 8 | 0 | 3 | 72.30 | 72.00 | 72.60 |
| 2026Q4 | S | 2026-08-05 | 9 | 0 | 3 | 72.27 | 72.00 | 72.60 |
| 2026Q4 | S | 2026-07-27 | 9 | 0 | 0 | 72.75 | 72.00 | 73.50 |
| 2026Q4 | S | 2026-07-20 | 9 | 0 | 1 | 72.75 | 72.00 | 73.50 |
| 2026Q4 | S | 2026-06-03 | 9 | 1 | 1 | 72.75 | 72.00 | 73.50 |
| 2026Q4 | S | 2026-05-13 | 9 | 1 | 1 | 72.74 | 72.00 | 73.50 |
| 2026Q4 | S | 2026-05-12 | 9 | 1 | 0 | 72.84 | 72.00 | 73.50 |
| 2026Q4 | S | 2026-05-06 | 9 | 5 | 0 | 72.84 | 72.00 | 73.50 |
| 2026Q4 | S | 2026-03-30 | 10 | 6 | 0 | 72.53 | 71.00 | 73.50 |
| 2026Q4 | S | 2026-03-13 | 9 | 6 | 0 | 72.42 | 71.00 | 73.00 |
Estimate history
| EPS, annual | 0.86 | 1.133 | 0.882 | 1.036 | 1.253 | 0.931 | 1.343 | 1.933 | 2.518 | 2.7054 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 0.488 | 0.488 | 0.481 | 0.602 | 0.753 | 0.678 | 0.681 | 0.695 | 0.651 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 100.867 | 105.568 | 117.232 | 129.366 | 154.424 | 161.651 | 193.484 | 219.863 | 249.602 | 269.36 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 54.819 | 55.717 | 59.871 | 64.232 | 61.046 | 64.453 | 66.551 | 70.382 | 67.97 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 19.265 | 19.609 | 20.157 | 20.523 | 21.923 | 22.087 | 22.327 | 22.549 | 22.773 | 22.88 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 22.483 | 22.549 | 22.594 | 22.637 | 22.682 | 22.773 | 22.848 | 22.865 | 22.88 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 269.36 | 249.60 | 219.86 | 193.48 | 161.65 | 154.42 | 129.37 | 117.23 | 105.57 |
| Cost of Goods Sold Incl. D&A | 79.57 | 76.71 | 74.75 | 72.53 | 62.94 | 59.24 | 49.79 | 39.82 | 33.39 |
| Gross Profit | 189.79 | 172.90 | 145.12 | 120.96 | 98.71 | 95.19 | 79.58 | 77.42 | 72.18 |
| Selling, General and Administrative Excl. Other | 115.09 | 104.98 | 92.73 | 83.88 | 68.93 | 58.76 | 51.26 | 56.23 | 51.44 |
| Research and Development | 16.86 | 14.14 | 15.65 | 16.97 | 13.29 | 11.80 | 10.10 | 9.28 | 8.20 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 74.70 | 67.91 | 52.39 | 37.08 | 29.78 | 36.42 | 28.32 | 21.18 | 20.73 |
| Interest Expense | 5.20 | 5.18 | 0.20 | 0.00 | 0.00 | 2.22 | 1.31 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.13 | 0.37 | 2.95 | 0.00 | 0.00 | - | - |
| Net Income Before Taxes | 81.83 | 75.18 | 56.88 | 39.48 | 27.49 | 34.29 | 27.36 | 21.68 | 28.44 |
| Income Taxes | 18.50 | 17.45 | 12.84 | 9.37 | 6.85 | 7.38 | 6.14 | 3.75 | 5.50 |
| Consolidated Net Income | 63.34 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 | 21.22 | 17.93 | 22.94 |
| Net Income From Continuing Operations | 63.34 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 | 21.22 | 17.93 | 22.94 |
| Net Income | 63.34 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 | 21.22 | 17.93 | 22.94 |
| EPS (Recurring) | 2.75 | 2.52 | 1.94 | 1.35 | 1.02 | 1.25 | 1.04 | 0.88 | 1.13 |
| EPS (Basic, Before Extraordinaries) | 2.78 | 2.55 | 1.96 | 1.35 | 0.94 | 1.27 | 1.05 | 0.91 | 1.18 |
| EPS (Diluted) | 2.71 | 2.52 | 1.93 | 1.34 | 0.93 | 1.25 | 1.04 | 0.88 | 1.13 |
| EBITDA | 85.47 | 78.33 | 62.00 | 46.60 | 39.22 | 45.90 | 36.54 | 26.60 | 25.06 |
| Non-Operating Income (Expense) | 12.34 | 12.46 | 4.82 | 2.76 | 0.66 | 0.08 | 0.35 | 0.50 | 7.71 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 6.44 | 6.18 | 5.19 | 4.20 | 3.30 | 2.54 | 2.21 | 1.93 | 1.86 |
| Price To Earnings Ratio | 29.21 | 29.21 | 50.54 | 46.58 | 48.11 | 40.00 | 39.13 | 40.77 | 20.90 |
| Price To Sales Ratio | 7.07 | 7.45 | 9.55 | 6.58 | 6.31 | 6.99 | 6.41 | 6.23 | 4.53 |
| Gross Margin | 70.46 | 69.27 | 66.00 | 62.52 | 61.07 | 61.64 | 61.51 | 66.04 | 68.37 |
| Operating Margin | 27.73 | 27.21 | 23.83 | 19.17 | 18.42 | 23.59 | 21.89 | 18.07 | 19.64 |
| Net Margin | 23.51 | 23.13 | 20.03 | 15.56 | 12.77 | 17.42 | 16.40 | 15.30 | 21.73 |
| Shares Outstanding | 22.88 | 22.77 | 22.55 | 22.33 | 22.09 | 21.92 | 20.52 | 20.16 | 19.61 |
| Market Capitalization | 1,808.05 | 1,808.05 | 2,071.68 | 1,263.66 | 1,012.48 | 1,096.93 | 823.85 | 718.68 | 462.92 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 67.97 | 70.38 | 66.55 | 64.45 | 61.05 | 64.23 | 59.87 | 55.72 |
| Cost of Goods Sold Incl. D&A | 20.70 | 21.03 | 19.57 | 18.26 | 16.53 | 20.70 | 19.87 | 17.13 |
| Gross Profit | 47.27 | 49.35 | 46.98 | 46.19 | 44.51 | 43.54 | 40.00 | 38.59 |
| Selling, General and Administrative Excl. Other | 29.57 | 28.95 | 29.21 | 27.36 | 24.20 | 27.39 | 27.37 | 25.67 |
| Research and Development | 4.42 | 4.85 | 4.06 | 3.53 | 2.97 | 3.54 | 4.09 | 3.62 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 17.70 | 20.40 | 17.77 | 18.83 | 20.31 | 16.14 | 12.63 | 12.92 |
| Interest Expense | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 | 1.29 | 0.20 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Net Income Before Taxes | 19.67 | 22.19 | 19.67 | 20.30 | 22.57 | 18.07 | 14.24 | 14.02 |
| Income Taxes | 4.65 | 5.14 | 3.99 | 4.72 | 5.21 | 4.29 | 3.23 | 2.84 |
| Consolidated Net Income | 15.02 | 17.05 | 15.68 | 15.58 | 17.36 | 13.78 | 11.01 | 11.18 |
| Net Income From Continuing Operations | 15.02 | 17.05 | 15.68 | 15.58 | 17.36 | 13.78 | 11.01 | 11.18 |
| Net Income | 15.02 | 17.05 | 15.68 | 15.58 | 17.36 | 13.78 | 11.01 | 11.18 |
| EPS (Recurring) | 0.65 | 0.70 | 0.68 | 0.68 | 0.75 | 0.60 | 0.48 | 0.49 |
| EPS (Basic, Before Extraordinaries) | 0.66 | 0.75 | 0.69 | 0.69 | 0.77 | 0.61 | 0.49 | 0.50 |
| EPS (Diluted) | 0.65 | 0.69 | 0.68 | 0.68 | 0.75 | 0.60 | 0.48 | 0.49 |
| EBITDA | 20.58 | 23.06 | 20.40 | 21.44 | 22.93 | 18.79 | 15.18 | 15.33 |
| Non-Operating Income (Expense) | 3.28 | 3.09 | 3.20 | 2.77 | 3.56 | 3.23 | 2.90 | 1.37 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 1.60 | 1.53 | 1.65 | 1.66 | 1.37 | 1.54 | 1.62 | 1.37 |
| Price To Earnings Ratio | 29.21 | 35.36 | 43.43 | 34.90 | 42.50 | 42.00 | 43.37 | 50.54 |
| Price To Sales Ratio | 7.07 | 8.97 | 9.81 | 7.46 | 8.86 | 8.10 | 8.49 | 9.60 |
| Gross Margin | 69.54 | 70.12 | 70.59 | 71.66 | 72.92 | 67.78 | 66.81 | 69.26 |
| Operating Margin | 26.03 | 28.98 | 26.71 | 29.22 | 33.27 | 25.13 | 21.09 | 23.19 |
| Net Margin | 22.10 | 24.22 | 23.56 | 24.18 | 28.44 | 21.45 | 18.39 | 20.07 |
| Shares Outstanding | 22.88 | 22.86 | 22.85 | 22.77 | 22.68 | 22.64 | 22.59 | 22.55 |
| Market Capitalization | 1,808.05 | 2,192.75 | 2,486.72 | 1,839.83 | 1,981.01 | 1,876.46 | 1,892.67 | 2,071.68 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 359.12 | 299.72 | 105.07 | 82.69 | 69.96 | 26.98 | 32.68 | 47.99 | 41.66 |
| Short Term Receivables | 33.61 | 30.06 | 25.06 | 22.04 | 19.63 | 19.55 | 16.57 | 15.72 | 15.00 |
| Inventories | 58.25 | 55.94 | 52.33 | 45.28 | 40.65 | 39.16 | 34.63 | 27.39 | 21.05 |
| Other Current Assets | 5.08 | 7.48 | 6.38 | 6.73 | 4.19 | 2.62 | 3.31 | 2.92 | 2.60 |
| Total Current Assets | 456.06 | 393.21 | 188.85 | 156.74 | 134.43 | 88.31 | 87.19 | 94.02 | 80.31 |
| Net Property, Plant & Equipment | 42.76 | 41.57 | 39.78 | 33.53 | 32.13 | 31.10 | 30.06 | 14.10 | 12.38 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 99.03 | 101.76 | 107.66 | 112.47 | 118.66 | 124.85 | 64.84 | 43.56 | 32.08 |
| Deferred Tax Assets | 0.76 | 1.43 | 1.00 | 1.75 | 1.57 | 1.69 | 1.08 | 1.22 | 1.38 |
| Other Assets | 17.08 | 13.85 | 9.49 | 5.98 | 6.03 | 6.86 | 5.16 | 0.19 | 0.18 |
| Total Assets | 615.69 | 551.82 | 346.78 | 310.48 | 292.80 | 252.81 | 188.34 | 153.09 | 126.32 |
| Short Term Debt Incl. Current Port. of LT Debt | 2.94 | 2.68 | 2.47 | 1.89 | 1.87 | 4.45 | 1.76 | 0.00 | 0.00 |
| Accounts Payable | 3.65 | 1.76 | 3.73 | 2.90 | 2.34 | 2.39 | 2.60 | 1.73 | 1.54 |
| Income Tax Payable | 1.66 | 0.64 | 0.39 | 0.45 | 0.55 | 2.39 | 1.00 | 2.93 | 0.70 |
| Other Current Liabilities | 28.07 | 25.53 | 23.28 | 20.09 | 17.05 | 15.90 | 15.49 | 15.10 | 10.94 |
| Total Current Liabilities | 36.32 | 30.61 | 29.88 | 25.33 | 21.81 | 25.14 | 20.85 | 19.76 | 13.19 |
| Long Term Debt | 182.65 | 183.00 | 16.62 | 14.71 | 14.07 | 50.32 | 13.96 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 1.74 | 0.09 | 0.11 | 0.07 | 0.07 | 0.13 | 1.18 | 0.48 | 2.18 |
| Other Liabilities | 1.47 | 0.83 | 2.27 | 2.17 | 2.70 | 4.64 | 4.21 | 2.61 | 1.19 |
| Total Liabilities | 222.17 | 214.53 | 48.88 | 42.27 | 38.65 | 80.24 | 40.20 | 22.85 | 16.55 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 393.52 | 337.29 | 297.90 | 268.20 | 254.15 | 172.57 | 148.14 | 130.24 | 109.77 |
| Total Shareholders Equity | 393.52 | 337.29 | 297.90 | 268.20 | 254.15 | 172.57 | 148.14 | 130.24 | 109.77 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 393.52 | 337.29 | 297.90 | 268.20 | 254.15 | 172.57 | 148.14 | 130.24 | 109.77 |
| Total Liabilities & Stockholders Equity | 615.69 | 551.82 | 346.78 | 310.48 | 292.80 | 252.81 | 188.34 | 153.09 | 126.32 |
| Book Value Per Share | 17.28 | 14.96 | 13.34 | 12.14 | 11.59 | 8.41 | 7.35 | 6.64 | 5.70 |
| Tangible Book Value Per Share | 12.93 | 10.44 | 8.52 | 7.05 | 6.18 | 2.33 | 4.13 | 4.42 | 4.03 |
| Full-Time Employees | 655 | 664 | 630 | 617 | 488 | 403 | 479 | 483 | 423 |
| Price to Book Ratio | 4.18 | 6.26 | 4.38 | 3.88 | 4.33 | 4.82 | 4.89 | 3.56 | 5.78 |
| Return on Assets | 9.89 | 9.80 | 9.16 | 6.84 | 9.86 | 9.62 | 10.51 | 16.42 | 15.05 |
| Return on Equity | 15.80 | 13.87 | 10.64 | 7.90 | 12.61 | 13.23 | 12.88 | 19.12 | 17.41 |
| Return on Invested Capital | 10.02 | 8.46 | 9.57 | 7.29 | 10.03 | 9.52 | 11.06 | 17.62 | 15.65 |
| Quick Ratio | 10.95 | 11.02 | 4.57 | 4.40 | 4.30 | 1.95 | 2.52 | 3.37 | 4.49 |
| Current Ratio | 12.56 | 12.85 | 6.32 | 6.19 | 6.16 | 3.51 | 4.18 | 4.76 | 6.09 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 63.34 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 | 21.22 | 17.93 | 22.94 |
| Depreciation | 10.78 | 10.42 | 9.67 | 9.52 | 9.43 | 11.07 | 8.39 | 5.42 | 4.32 |
| Other Funds (Non Cash) | 13.90 | 12.54 | 10.97 | 7.60 | 8.89 | 7.01 | 4.65 | 3.89 | -3.96 |
| Funds from Operations | 90.32 | 83.00 | 64.23 | 48.01 | 38.78 | 45.07 | 33.94 | 28.07 | 21.16 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -14.12 | -1.75 | -20.10 | -11.25 | -13.40 | -9.96 | 0.86 | -13.89 | -1.65 |
| Cash from Operating Activities | 76.20 | 81.25 | 44.12 | 36.75 | 25.38 | 35.10 | 34.80 | 14.18 | 19.51 |
| Capital Expenditures | -9.21 | -6.78 | -6.96 | -7.26 | -3.23 | -4.88 | -2.98 | -3.76 | -3.05 |
| Net Assets From Acquisitions | -2.00 | -1.90 | 0.00 | -0.90 | 0.00 | 0.00 | -72.63 | -21.24 | -12.28 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.86 | 0.00 | 2.02 | 0.00 | 7.40 |
| Purchase or Sale of Investments | -46.03 | -56.26 | -193.16 | -16.55 | -8.00 | -56.19 | 20.70 | 0.90 | 0.88 |
| Purchase of Investments | -989.30 | -641.33 | -277.94 | -16.55 | -8.00 | -59.19 | -2.21 | -22.70 | -19.62 |
| Sale Or Maturity of Investments | 943.27 | 585.07 | 84.78 | 0.00 | 0.00 | 3.00 | 22.90 | 23.60 | 20.50 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -57.23 | -64.94 | -200.12 | -24.71 | -10.37 | -61.08 | -52.89 | -24.10 | -7.05 |
| Cash Dividends Paid | -21.68 | -18.11 | -14.38 | -12.45 | -10.99 | -9.34 | -7.70 | -6.74 | -5.45 |
| Change in Capital Stock | 6.64 | 6.82 | 4.72 | 5.32 | 2.82 | 62.44 | 5.40 | 4.17 | 2.23 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | -1.72 | -0.85 | -0.64 | -0.80 | -0.57 | -0.68 | -0.74 |
| Sale of Common Pref Stock | 6.64 | 6.82 | 6.44 | 6.17 | 3.47 | 63.24 | 5.97 | 4.86 | 2.97 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 6.44 | 6.17 | 3.47 | 63.24 | 5.97 | 4.86 | 2.97 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 167.76 | 0.00 | 0.00 | -39.00 | 37.25 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 167.76 | 0.00 | 0.00 | -39.00 | 37.25 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 167.76 | 0.00 | 0.00 | 0.00 | 63.25 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -39.00 | -26.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -1.79 | -3.25 | 0.00 | 0.00 | -1.07 | -0.40 | -2.80 | -2.06 | -1.20 |
| Other Financing Activities Uses | -1.79 | -3.25 | 0.00 | 0.00 | -1.07 | -0.40 | -2.80 | -2.06 | -1.20 |
| Cash from Financing Activities | -16.83 | -14.54 | 158.10 | -7.13 | -9.23 | 13.70 | 32.16 | -4.62 | -4.42 |
| Exchange Rate Effect | -0.14 | 0.86 | -0.77 | 0.23 | -0.49 | -0.64 | 0.91 | 0.01 | -0.81 |
| Net Change in Cash | 2.00 | 2.63 | 1.34 | 5.13 | 5.28 | -12.91 | 14.98 | -14.53 | 7.22 |
| Free Cash Flow | 67.00 | 74.47 | 37.16 | 29.49 | 22.15 | 30.22 | 31.82 | 10.42 | 16.45 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 42.05 | 32.99 | 92.12 | 74.70 | 91.42 | 51.65 | 34.38 | 198.46 | 43.47 |
| Deferred Taxes & Investment Tax Credit | - | 2.31 | -0.45 | 0.78 | -0.18 | 0.08 | -0.33 | 0.82 | -2.15 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 389.72 | 376.24 | 367.23 | 359.12 | 343.06 | 319.49 |
| Short Term Receivables | 35.88 | 35.68 | 35.77 | 33.61 | 32.42 | 36.54 |
| Inventories | 57.08 | 57.94 | 57.77 | 58.25 | 58.93 | 57.46 |
| Other Current Assets | 8.64 | 5.87 | 4.00 | 5.08 | 5.76 | 5.72 |
| Total Current Assets | 491.31 | 475.74 | 464.77 | 456.06 | 440.17 | 419.20 |
| Net Property, Plant & Equipment | 48.97 | 49.59 | 48.38 | 42.76 | 42.50 | 41.87 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 95.24 | 96.49 | 97.62 | 99.03 | 97.66 | 99.10 |
| Deferred Tax Assets | 0.75 | 0.73 | 0.74 | 0.76 | 0.85 | 1.46 |
| Other Assets | 19.76 | 18.00 | 18.02 | 17.08 | 16.89 | 15.97 |
| Total Assets | 656.03 | 640.55 | 629.53 | 615.69 | 598.07 | 577.59 |
| Short Term Debt Incl. Current Port. of LT Debt | 3.19 | 3.44 | 3.45 | 2.94 | 2.79 | 2.83 |
| Accounts Payable | 4.16 | 3.24 | 4.18 | 3.65 | 3.46 | 4.91 |
| Income Tax Payable | 0.89 | 0.85 | 5.28 | 1.66 | 1.96 | 1.09 |
| Other Current Liabilities | 26.38 | 22.41 | 20.47 | 28.07 | 25.07 | 21.98 |
| Total Current Liabilities | 34.62 | 29.93 | 33.37 | 36.32 | 33.29 | 30.82 |
| Long Term Debt | 185.66 | 186.81 | 186.37 | 182.65 | 182.84 | 183.06 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 2.17 | 2.00 | 1.85 | 1.74 | 2.09 | 0.10 |
| Other Liabilities | 1.46 | 1.46 | 1.31 | 1.47 | 0.93 | 0.93 |
| Total Liabilities | 223.90 | 220.21 | 222.90 | 222.17 | 219.15 | 214.91 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 432.13 | 420.34 | 406.62 | 393.52 | 378.92 | 362.69 |
| Total Shareholders Equity | 432.13 | 420.34 | 406.62 | 393.52 | 378.92 | 362.69 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 432.13 | 420.34 | 406.62 | 393.52 | 378.92 | 362.69 |
| Total Liabilities & Stockholders Equity | 656.03 | 640.55 | 629.53 | 615.69 | 598.07 | 577.59 |
| Book Value Per Share | 18.89 | 18.38 | 17.80 | 17.28 | 16.71 | 16.02 |
| Tangible Book Value Per Share | 14.72 | 14.16 | 13.52 | 12.93 | 12.40 | 11.64 |
| Full-Time Employees | - | - | - | 655 | - | - |
| Price to Book Ratio | 4.18 | 5.39 | 6.32 | 4.85 | 5.46 | 5.40 |
| Return on Assets | 10.10 | 10.78 | 10.53 | 9.89 | 10.94 | 10.02 |
| Return on Equity | 15.62 | 16.77 | 16.55 | 15.80 | 15.02 | 13.81 |
| Return on Invested Capital | 2.43 | 2.81 | 2.64 | 2.70 | 3.09 | 2.52 |
| Quick Ratio | 12.54 | 13.96 | 12.20 | 10.95 | 11.45 | 11.74 |
| Current Ratio | 14.19 | 15.89 | 13.93 | 12.56 | 13.22 | 13.60 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 15.02 | 17.05 | 15.68 | 15.58 | 17.36 | 13.78 |
| Depreciation | 2.88 | 2.66 | 2.62 | 2.60 | 2.61 | 2.65 |
| Other Funds (Non Cash) | 4.32 | 2.65 | 3.04 | 3.88 | 0.98 | 3.70 |
| Funds from Operations | 22.23 | 22.36 | 21.35 | 24.38 | 20.96 | 20.13 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.24 | -6.40 | -6.25 | -1.23 | 7.80 | 0.16 |
| Cash from Operating Activities | 21.99 | 15.96 | 15.09 | 23.16 | 28.76 | 20.29 |
| Capital Expenditures | -2.33 | -2.31 | -2.78 | -1.78 | -2.28 | -1.34 |
| Net Assets From Acquisitions | -0.04 | -0.11 | -0.04 | -1.80 | 0.00 | -0.05 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -13.84 | -8.65 | -10.29 | -13.24 | -25.17 | -14.96 |
| Purchase of Investments | -159.55 | -80.57 | -150.87 | -598.31 | -25.17 | -14.96 |
| Sale Or Maturity of Investments | 145.71 | 71.92 | 140.57 | 585.07 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -16.21 | -11.08 | -13.12 | -16.82 | -27.45 | -16.35 |
| Cash Dividends Paid | -5.72 | -5.72 | -5.71 | -4.54 | -4.54 | -4.52 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.74 | 0.78 | 2.95 | 2.17 | 1.58 | 2.36 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 |
| Sale of Common Pref Stock | 0.74 | 0.78 | 2.95 | 2.17 | 1.58 | 1.76 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | -0.11 | -0.46 | -1.22 | 0.00 | -0.60 |
| Other Financing Activities Uses | 0.00 | -0.11 | -0.46 | -1.22 | 0.00 | -0.60 |
| Cash from Financing Activities | -4.97 | -5.05 | -3.22 | -3.59 | -2.95 | -2.76 |
| Exchange Rate Effect | 0.06 | -0.06 | -0.15 | 0.01 | -0.05 | 0.66 |
| Net Change in Cash | 0.87 | -0.23 | -1.39 | 2.75 | -1.68 | 1.84 |
| Free Cash Flow | 19.66 | 13.65 | 12.31 | 21.38 | 26.48 | 18.95 |
| Price to Free Cash Flow | 42.05 | 44.14 | 42.03 | 33.05 | 43.51 | 52.68 |
Revenue breakdown
| Surgical & Medical Instruments & Apparatus | 2024: 219.86M 2025: 249.60M |
|---|---|
| Canada | 2024: 13.67M 2025: 15.25M |
| Germany | 2024: 14.42M 2025: 17.90M |
| Other Countries | 2024: 52.07M 2025: 61.67M |
| United Kingdom | 2024: 10.96M 2025: 13.22M |
| United States | 2024: 128.74M 2025: 141.57M |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.78% | 1.7M | 21.3M | 327.48K |
| 2026-10-15 | 8.34% | 1.8M | 21.3M | 326.08K |
| 2026-09-30 | 8.17% | 1.7M | 21.3M | 335.87K |
| 2026-09-15 | 7.95% | 1.7M | 21.3M | 362.13K |
| 2026-08-31 | 7.15% | 1.5M | 21.3M | 364.71K |
| 2026-08-14 | 7.56% | 1.6M | 21.3M | 363.32K |
| 2026-07-31 | 6.79% | 1.4M | 21.3M | 319.97K |
| 2026-07-15 | 6.96% | 1.5M | 21.3M | 302.46K |
| 2026-06-30 | 6.38% | 1.4M | 21.3M | 276.80K |
| 2026-06-15 | 6.01% | 1.3M | 21.3M | 263.73K |
| 2026-05-29 | 5.59% | 1.2M | 21.3M | 251.38K |
| 2026-05-15 | 5.42% | 1.2M | 21.3M | 252.97K |
| 2026-04-30 | 5.48% | 1.2M | 21.2M | 222.05K |
| 2026-04-15 | 6.50% | 1.4M | 21.1M | 219.09K |
| 2026-03-31 | 6.38% | 1.3M | 20.9M | 215.95K |
| 2026-03-13 | 6.02% | 1.3M | 20.9M | 188.19K |
| 2026-02-27 | 5.85% | 1.2M | 20.9M | 180.76K |
| 2026-02-13 | 5.62% | 1.2M | 20.8M | 162.96K |
| 2026-01-30 | 5.54% | 1.2M | 20.8M | 173.08K |
| 2026-01-15 | 5.90% | 1.2M | 20.8M | 170.00K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 40.00 | 36.50 | 41.50 | 0.00 | 4.044 | 0.00 | 0.00 | 0.893 | -0.669 | 0.023 |
| call | 45.00 | 31.60 | 36.50 | 0.00 | 3.475 | 0.00 | 0.00 | 0.875 | -0.648 | 0.025 |
| call | 50.00 | 26.60 | 31.50 | 0.00 | 2.945 | 0.00 | 0.00 | 0.854 | -0.623 | 0.028 |
| call | 55.00 | 21.60 | 26.30 | 0.00 | 2.407 | 0.00 | 0.00 | 0.830 | -0.592 | 0.031 |
| call | 60.00 | 16.60 | 21.40 | 0.00 | 2.023 | 0.00 | 0.00 | 0.801 | -0.554 | 0.034 |
| call | 65.00 | 11.60 | 16.40 | 0.00 | 1.622 | 0.00 | 0.00 | 0.764 | -0.508 | 0.038 |
| call | 70.00 | 6.60 | 11.30 | 0.00 | 1.203 | 0.00 | 0.00 | 0.714 | -0.450 | 0.042 |
| call | 75.00 | 2.00 | 6.50 | 0.00 | 0.819 | 0.00 | 0.00 | 0.649 | -0.338 | 0.046 |
| call | 80.00 | 0.00 | 4.90 | 5.08 | 1.072 | 0.00 | 0.00 | 0.505 | -0.280 | 0.049 |
| call | 85.00 | 0.05 | 0.75 | 0.05 | 0.528 | 44.00 | 3.00 | 0.242 | -0.131 | 0.039 |
| call | 90.00 | 0.00 | 4.90 | 0.50 | 0.774 | 8.00 | 0.00 | 0.158 | -0.131 | 0.030 |
| call | 95.00 | 0.00 | 4.90 | 0.80 | 1.348 | 2.00 | 0.00 | 0.220 | -0.277 | 0.037 |
| call | 100 | 0.00 | 4.00 | 0.80 | 1.553 | 1.00 | 0.00 | 0.198 | -0.300 | 0.034 |
| call | 105 | 0.00 | 4.90 | 0.00 | 1.746 | 0.00 | 0.00 | 0.183 | -0.320 | 0.033 |
| call | 110 | 0.00 | 4.90 | 0.00 | 1.921 | 0.00 | 0.00 | 0.171 | -0.338 | 0.031 |
| call | 115 | 0.00 | 4.90 | 0.00 | 2.083 | 0.00 | 0.00 | 0.161 | -0.352 | 0.030 |
| call | 120 | 0.00 | 4.90 | 0.00 | 2.233 | 0.00 | 0.00 | 0.153 | -0.366 | 0.029 |
| put | 40.00 | 0.00 | 4.90 | 0.00 | 5.192 | 0.00 | 0.00 | -0.107 | -0.659 | 0.023 |
| put | 45.00 | 0.00 | 4.90 | 0.00 | 4.512 | 0.00 | 0.00 | -0.125 | -0.641 | 0.025 |
| put | 50.00 | 0.00 | 4.90 | 0.00 | 3.900 | 0.00 | 0.00 | -0.146 | -0.615 | 0.028 |
| put | 55.00 | 0.00 | 4.90 | 0.00 | 3.345 | 0.00 | 0.00 | -0.170 | -0.584 | 0.031 |
| put | 60.00 | 0.00 | 4.90 | 0.00 | 2.830 | 0.00 | 0.00 | -0.200 | -0.545 | 0.035 |
| put | 65.00 | 0.00 | 4.90 | 0.60 | 2.344 | 10.00 | 0.00 | -0.237 | -0.498 | 0.038 |
| put | 70.00 | 0.00 | 4.90 | 0.80 | 1.873 | 19.00 | 0.00 | -0.288 | -0.439 | 0.042 |
| put | 75.00 | 0.00 | 4.90 | 2.05 | 1.399 | 1.00 | 0.00 | -0.359 | -0.325 | 0.046 |
| put | 80.00 | 0.05 | 4.90 | 3.60 | 0.908 | 2.00 | 0.00 | -0.495 | -0.274 | 0.049 |
| put | 85.00 | 4.00 | 8.50 | 5.40 | 0.999 | 6.00 | 0.00 | -0.744 | -0.139 | 0.040 |
| put | 90.00 | 9.00 | 13.50 | 0.00 | 1.295 | 0.00 | 0.00 | -0.820 | -0.146 | 0.032 |
| put | 95.00 | 13.70 | 18.50 | 0.00 | 1.491 | 0.00 | 0.00 | -0.779 | -0.269 | 0.037 |
| put | 100 | 18.80 | 23.50 | 0.00 | 1.713 | 0.00 | 0.00 | -0.801 | -0.293 | 0.034 |
| put | 105 | 23.80 | 28.50 | 0.00 | 1.969 | 0.00 | 0.00 | -0.817 | -0.313 | 0.033 |
| put | 110 | 28.80 | 33.50 | 0.00 | 2.155 | 0.00 | 0.00 | -0.829 | -0.329 | 0.031 |
| put | 115 | 33.80 | 38.50 | 29.80 | 2.327 | 1.00 | 0.00 | -0.838 | -0.344 | 0.030 |
| put | 120 | 38.80 | 43.50 | 0.00 | 2.487 | 0.00 | 0.00 | -0.846 | -0.357 | 0.029 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-10-15 | 8-K | Current report | 2026-10-09 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-01 | SEC |
| 2026-08-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-04 | 8-K | Current report | 2026-08-04 | SEC |
| 2026-07-29 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-07-27 | SCHEDULE 13G | SEC | ||
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-04 | SEC |
| 2026-06-05 | 8-K | Current report | 2026-06-02 | SEC |
| 2026-05-29 | SD | Specialized Disclosure Report | SEC | |
| 2026-05-14 | SCHEDULE 13G/A | SEC | ||
| 2026-05-11 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-07 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 6.34M | 5 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 6.67M | 3 |
| 2026-02 | 0 | 0 | 17.03M | 3 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 61.22% |
| BlackRock, Inc. | 14.32% |
| FIRST TRUST ADVISORS LP | 4.79% |
| CONGRESS ASSET MANAGEMENT CO | 4.20% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.17% |
| Copeland Capital Management, LLC | 4.04% |
| STATE STREET CORP | 3.94% |
| Conestoga Capital Advisors, LLC | 3.84% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 3.22% |
Funds
| Fund | % owned |
|---|---|
| Miller Market Neutral Income Fund | 17.50% |
| American Beacon SSI Alternative Income Fund | 10.90% |
| iShares Core S&P Small-Cap ETF | 5.54% |
| Fidelity Convertible Securities Fund | 4.71% |
| ABSOLUTE FLEXIBLE FUND | 4.38% |
| First Trust SMID Cap Rising Dividend Achievers ETF | 4.27% |
| Empower Core Strategies: Flexible Bond Fund | 3.83% |
| CONESTOGA SMALL CAP FUND | 3.80% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.02% |
| MEDIUM-DURATION BOND FUND | 2.88% |
OakChart. LMAT. Cached 15 minutes.